eConsent webinar

– On demand by filling out the form on the right

eConsent is rapidly becoming the new consent standard for trials. Due to COVID and a general need to simplify the consent and tracking process, more and more trials are using this solution. In our webinar, we will look into selecting the right eConsent solution to your study type and how to simplify the eSignature process for the patient.

Site benefits of eConsent are essential, and most sites find eConsent is easier to use and makes it easy to fulfil the regulatory requirements. We will go through the site process of using eConsent for both initial- and re-consent, and how this is linked to randomization and EDC.

    You must agree before submitting.

    For more information on how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

    Input this code: captcha

    Subscribe to our newsletter or explore our webinars.


    John Aggerholm

    John Aggerholm

    Project Director

    John Aggerholm is the founder of the company. Before founding HERAX, John worked 7 years for a daughter company of Novo Nordisk A/S, as Vice President for eClinical Process Consulting, specializing in improvement of clinical processes in R&D and the design and execution of Digitalization and eClinical programs. ​Before joining the Novo group, John worked 5 years as Chief Information Officer in IBM Denmark, and before that worked in IT and Clinical Operations at Henri Beaufour Institute Inc. in Washington D.C. (US).
    Sarah Sendrup

    Sarah Sendrup

    Senior Consultant

    Sarah is a Pharma Business and IT Consultant. She specializes in IT Quality, running IT implementation projects, optimizing business processes and developing quality documentation (SOPs) for computerized systems in Life Science. ​ Sarah has a strong background within pharmaceutical research, biopharmaceutical production and documentation and has a Master of Science in Engineering in Biotechnology. She has an analytical mindset and is driven by solving problems and making a difference.​ Before joining HERAX, Sarah has work in both research at the University of Copenhagen and in production in the pharmaceutical industry.